In the Know

Avoid Costly FCPA Mistakes! The Do’s and Don’ts for Life Sciences Companies
AGG Seminars & Webinars
December 9, 2014

The attorneys of Arnall Golden Gregory LLP's International Business and Food and Drug Practices invite you to attend a complimentary one-hour webinar, “Avoid Costly FCPA Mistakes! The Do’s and Don’ts for Life Sciences Companies” on December 9, 2014.

Life sciences companies are in the crosshairs of enhanced Foreign Corrupt Practices Act (FCPA) enforcement by the US Justice Department. This webinar will explain recent FCPA developments and provide practical, best practices for effective compliance efforts. Many life science companies research, develop, test, or sell their products abroad, and deal with foreign officials on a regular basis. Foreign officials often make the purchasing decision for covered products, as many foreign health systems are operated by active local governments. Life sciences companies also make significant use of distributors, agents and third parties in their international operations, which can present a compliance challenge.

Register Now to hear AGG partner, Michael E. Burke, and associate, Edward P. Cadagin, discuss how Life Sciences companies can avoid costly FCPA mistakes.

Credits: This webinar is approved for 1 hour of CLE credit by the State Bar of Georgia.